Precise metabolic modeling in post-omics era: accomplishments and perspectives

Kong, Yawen; Chen, Haiqin; Huang, Xinlei; Chang, Lulu; Yang, Bo; Chen, Wei

doi:10.1080/07388551.2024.2390089

Critical Reviews in Biotechnology

2024

DOI: 10.1080/07388551.2024.2390089

|View full text |Cite

Precise metabolic modeling in post-omics era: accomplishments and perspectives

Yawen Kong,

Haiqin Chen,

Xinlei Huang

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 126 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Natural ingredients in the regulation of abnormal lipid peroxidation: a potential therapy for pulmonary diseases

Liu,

Wang,

et al. 2024

Front. Pharmacol.

View full text Add to dashboard Cite

Pulmonary diseases are a major category of diseases that pose a threat to human health. The most common drugs currently used to treat lung diseases are still chemical drugs, but this may lead to drug resistance and damage to healthy organs in the body. Therefore, developing new drugs is an urgent task. Lipid peroxidation is caused by the disruption of redox homeostasis, accumulation of reactive oxygen species (ROS), depletion of glutathione (GSH), and inactivation of glutathione peroxidase 4 (GPX4). Lipid peroxidation is closely related to the occurrence and progression of respiratory diseases, including acute lung injury, asthma, pulmonary fibrosis, pulmonary hypertension, chronic obstructive pulmonary disease, and lung cancer. Natural ingredients have high safety, high availability, and low cost, and can regulate lipid peroxidation through multiple pathways and targets, making them valuable new drugs. This article aims to summarize the pharmacology and mechanism of natural ingredients targeting lipid peroxidation in the treatment of lung diseases. The reviewed data indicate that natural ingredients are a promising anti-lipid peroxidation drug, mainly alleviating lipid peroxidation through the cystine/glutamate antiporter (System Xc−)/GSH/GPX4 axis, Nrf2 pathway, and ROS pathway. In the future, it will still be necessary to further study the mechanisms of natural products in treating pulmonary diseases through lipid peroxidation and conduct multi-center, large-sample clinical trials to promote the development of new drugs.

show abstract

Natural ingredients in the regulation of abnormal lipid peroxidation: a potential therapy for pulmonary diseases

Liu,

Wang,

et al. 2024

Front. Pharmacol.

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Precise metabolic modeling in post-omics era: accomplishments and perspectives

Cited by 1 publication

References 126 publications

Natural ingredients in the regulation of abnormal lipid peroxidation: a potential therapy for pulmonary diseases

Natural ingredients in the regulation of abnormal lipid peroxidation: a potential therapy for pulmonary diseases

Contact Info

Product

Resources

About